Company Reports

CFG 4Q20 : Very Optimistic, Still Has Issues

01/20/2021

CFG seems to be in another optimistic world of economic rebound, buybacks and being a buyer in the M&A world. We are more pessimistic and are a Sell on Stock and benchmark bonds. Systemic risk is low and counterparty risk is Low-to-Medium. 


GS 4Q20: Crushes Consensus, Advancing on Strategics, Shrugs off 1MDB

01/19/2021

Goldman Sachs had an explosive 4Q20 as its equities machine pumped out windfall gains in underwriting and trading. Still, it made good progress on its strategic targets. We move to Buy on Stock, maintain Sell on benchmark bonds. Systemic and counterparty risk is Medium. 


PNC 4Q20: Waiting for BBVA USA Close, Tough Rates Environment

01/19/2021

PNC in deal closing flight pattern as it waits for the BBVA USA deal to close in the summer. Still experiencing rate pressures as most banks are, but without a stock buyback route. We are Neutral on Stock, Sell on benchmark bonds. Systemic risk Very Low. Counterparty risk Low. 


JPM 4Q20: Lots of Outlook, No Investor Day

01/15/2021

JPMorgan  gave its 2021 outlook in its 4Q20 release and is looking for greater technological prowess with commensurate investment spending. Needs to compete against Big Tech, growing FinTech players and foreign bank competition mostly from China banks. Move to Buy on Stock, Sell on benchmark bonds. Regulatory and counterparty risks decline to Very Low and Low, respectively with vaccine rollouts. 


Citi Update: In New CEO Neverland: FCF Farce!

12/17/2020

Citi is playing three-card monte on it operating/risk management overhaul as it trys to get the focus on the new CEO, instead of the breakdown in its risk mgt and infrastructure needs. Sell on Stock and benchmark Bonds. Regulatory & counterparty risk back to High. 


M&A Chat: HBAN Buys TCF TCBB of Banking?

12/16/2020

HBAN pulls the trigger on the in-region acquisition of TCF Financial. We explore the economic earnings and capital benefits of the deal to HBAN. 


USB: M&A Buyer or By-Stander?

12/11/2020

U.S. Bancorp has lots of strategic options as it decides to go more digital banking/alliance(s) or jump back into physical bank M&A. We believe that it has the luxury to wait out better bank M&A valuaitons. Buy on Stock, Sell on benchmark bonds, Low risk indicators in regulatory and counterparty risk. 


WFC @ GS: Likes Long Term, Short Term Systemically Creepy

12/08/2020

Wells Fargo CEO sounded chipper on GS Financial Services zoom call. Still, there is too much wood to chop in its restructuring to be so sanguine. Still a Sell on Stock, Perpetual Preferred Stock, and benchmark Bonds. Regulatory risk is Very High and counterparty risk is High. 


TFC: Stuck Between a Merger and a Pandemic

11/24/2020

Truist loaded up on perpetual preferred stock YTD to keep the regulators at bay as it deals with merger cost savings delays and an overleveraged balance sheet going into pandemic. Catching up on all fronts. Still commond dividend may be more at risk versus other big regionals. Sell Stock and benchmark Bond, Preferred stock fully priced. Very Low regulatory risk and Low counterparty risk. 


Regions Financial: M&A Mahjong: Who Shall Meld?

11/22/2020

Regions Financial continues to stay independent as the latest PNC action bypassed it. We analyse and update our regional bank M&A stratego to see why and when it will be purchased. Seems like a while. Sell capital structure (equity & debt) and counterparty & regulatory indicators are High risk. 


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40